Neuroscience
Parkinson's Disease
100%
Fibroblast Growth Factor
80%
Oxidopamine
61%
Dopaminergic Neuron
58%
In Vivo
44%
Striatum
43%
Neuroprotection
40%
L-DOPA
40%
Tyrosine Hydroxylase
40%
Agonist
40%
CD71 Antigen
40%
Cell Loss
40%
Dyskinesia
32%
Substantia Nigra Pars Compacta
26%
Substantia nigra
16%
Neuroprotective Agent
16%
Fibroblast Growth Factor Receptor
13%
Receptor
13%
Blood Brain Barrier
13%
Mitogen Activated Protein Kinase 3
13%
Neurotrophin Receptor
13%
Receptor Agonists
13%
Parenchyma
13%
Astrocyte
10%
Soma
8%
Magnetic Resonance Imaging
8%
Neurodegenerative Disorder
8%
Microglia
8%
Carisoprodol
8%
Immunohistochemistry
6%
Receptor Antagonist
6%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
49%
Drug Repositioning
40%
Oxidopamine
40%
Fibroblast Growth Factor
40%
Diseases
32%
Drug Discovery
16%
Degenerative Disease
8%
Clinical Trial
8%
Repurposing
8%
Preclinical Study
8%
Medicine and Dentistry
Oxidopamine
40%
Fibroblast Growth Factor
40%
Cell Loss
40%
Parkinson's Disease
8%